NCT07265921 2025-12-05Solid TumorsJiangsu Simcere Pharmaceutical Co., Ltd.Phase 1 Recruiting232 enrolled
NCT07123415 2025-11-19A Phase 1 Study of APX-343A as Monotherapy or in Combination With Pembrolizumab in Subjects With Advanced Solid TumorsAptabio Therapeutics, Inc.Phase 1 Recruiting110 enrolled